Pasithea Therapeutics (KTTA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov25

Pasithea Therapeutics Announces Positive PAS-004 Clinical Trial Data and Receives ALS Association Funding

21:53

Pasithea Therapeutics Releases Investor Presentation on Next-Generation MEK Inhibitor PAS-004

05:42

Nov14

Pasithea Therapeutics released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -2.6782

04:00

Pasithea Therapeutics released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -0.408

04:00

Aug15

Pasithea Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.66

03:00

Pasithea Therapeutics released FY2025 Semi-Annual earnings on August 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.8495

03:00

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.037 M, EPS -0.408

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -3.716 M, EPS -0.6587

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.563 M, EPS -1.6114

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More